Revolutionising Cancer Care

The Mark Foundation Institute for Integrated Cancer Medicine (MFICM) hosted at the University of Cambridge, with funding from The Mark Foundation for Cancer Research and the Cancer Research UK Cambridge Centre, aims to revolutionise cancer care by re-inventing the treatment pathway for patients.

Re-inventing the Patient Pathway

Research Areas

Breast Cancer

Read more Arrow

Ovarian Cancer

Read more Arrow

Pancreatic Cancer

Read more Arrow

Renal Cancer

Read more Arrow

Latest Updates

You can find a full list of media coverage about MFICM on the News page

Imaging technique predicts treatment response in lab models of ovarian cancer

Imaging technique predicts treatment response in lab models of ovarian cancer

An MRI-based imaging technique developed at the University of Cambridge predicts the response of ovarian cancer tumours to treatment, and rapidly reveals how well treatment is working, in patient-derived cell models. The technique, called hyperpolarised carbon-13 imaging, can increase the detected signal in an MRI scanner by more than 10,000 times. Scientists have found that […]

Read More Arrow
Cambridge MedAI Seminar: “AI in Histopathology: Practical Lessons from an Unconventional Case Study” and “Next generation technology for next generation trials”

Cambridge MedAI Seminar: “AI in Histopathology: Practical Lessons from an Unconventional Case Study” and “Next generation technology for next generation trials”

Wednesday 29 January 2025, 12-1pm at the Jeffrey Cheah Biomedical Centre (Main Lecture Theatre), University of Cambridge

Read More Arrow
ICM Research in Focus – Kevin Brindle – Reflections on a lifetime in imaging research

ICM Research in Focus – Kevin Brindle – Reflections on a lifetime in imaging research

Professor Kevin Brindle talks about his life’s work in imaging research as he reaches retirement.

Read More Arrow

Key statistics

 
 
 
 
 
 
Statistics map
Connect

Connect with us

The Mark Foundation Institute for Integrated Cancer Medicine (MFICM) at the University of Cambridge aims to revolutionise cancer care by affecting patients along their treatment pathway.

Find out more

Connect